FDA Cites City Market, Inc. in 2026-05-15 Warning Letter — Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions
Letter issued · posted to fda.gov .
Subject as published: Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions
TL;DR
At a glance: FDA issued a Warning Letter to City Market, Inc. on 2026-05-15 citing: Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions. Full letter: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/city-market-inc-727003-05152026
Argus analysis
City Market, Inc. (MARCS-CMS 727003) received an FDA Warning Letter dated May 15, 2026 from the Human Foods Program. The letter cites: Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions. FDA posts Warning Letters to fda.gov after an internal review period; this one was made public on June 2, 2026.
CGMP citations typically reference 21 CFR Part 211 (finished pharmaceuticals) or Part 111 (dietary supplements), covering subjects such as identity testing of incoming components, validated cleaning procedures, batch-failure investigations, and stability program design. Repeat or systemic findings are what typically drive FDA toward import alert or consent decree escalation.
FDA Warning Letters typically specify a 15-working-day response window for the recipient to detail corrective actions. Compliance teams at peer companies in the same CGMP (Current Good Manufacturing Practice) category commonly use a newly published letter as a prompt to re-check their own procedures against the same citation, and to watch fda.gov for a close-out letter confirming the cited firm's corrective action was accepted — or, absent one, for escalation to import alert, injunction, or product seizure.
Severity context
Critical severity. Typically reserved for data integrity, sterile-product CGMP, or repeat violations — matters that historically precede injunctions, consent decrees, or import alerts.
Regulatory background
CGMP citations typically reference 21 CFR Part 211 (drugs) or 21 CFR Part 600 (biologics). Common subjects include identity testing of incoming components (211.84), validated cleaning procedures (211.67), and stability program design (211.166).
What peer compliance teams typically do next
Most compliance officers at peer companies use a Warning Letter against a named entity as a checklist for their own CAPA program. Common steps: pull the verbatim FDA letter; map each cited 21 CFR section against the team’s SOP library; confirm CAPA coverage; brief the QMR (Quality Management Review) on whether the cited subject matter is in scope for the next internal audit. The 15-business-day response window applies to the cited entity, not to peers — but a documented internal review against the cited subjects is what regulators expect to see if a peer is later inspected on the same topic.
Excerpt from the FDA Warning Letter (public domain, 17 USC §105)
WARNING LETTER City Market, Inc. MARCS-CMS 727003 — May 15, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA ELECTRONIC DELIVERY Product: Food & Beverages Recipient: Recipient Name Frank H. Owens Jr. Recipient Title Owner City Market, Inc. 1508 Gloucester Street Brunswick , GA 31520-7143 United States frankowensjr76@gmail.com Issuing Office: Human Foods Program United States May 15, 2026 WARNING LETTER Re: CMS #727003 Dear Mr. Owens: The United States Food and Drug Administration (FDA) conducted an inspection of your seafood processing facility located at 1508 Gloucester Street, Brunswick, GA 31520, from January 7, 2026, through January 9, 2026. During our inspection, the FDA investigator found serious violations of the seafood Hazard Analysis and Critical Control Point (HACCP) regulation, Title 21, Code of Federal Regulations, Part 123. Based on FDA’s inspectional findings we have determined that your ready-to-eat pasteurized canned crab meat is adulterated within the meaning of section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the Act) (21 U.S.C. § 342(a)(4)) in that they have been prepared, packed, or held under insanitary conditions whereby they may have been rendered injurious to health. Furthermore, in accordance with 21 CFR 123.6(g), failure of a processor of fish or fishery products to have and implement a HACCP plan that complies with 21 CFR 123.6 whenever a HACCP plan is necessary or otherwise operate in accordance with the requirements of Part 123, renders the fish or fishery products adulterated within the meaning of section 402(a)(4) of the Act, 21 U.S.C. § 342(a)(4). You may find the Act, the seafood HACCP regulation, and the June 2022 Edition of the Fish and Fisheries Products Hazards and Controls Guidance (the Hazards Guide) through links in FDA's home page at www.fda.gov. At the conclusion of the inspection, the FDA investigator issued your facility a Form FDA 483 (FDA-483), Inspectional Observations, listing the deviations found at your firm. To date, we have not received a response to the FDA-483 issued to you on January 9, 2026. We are issuing this letter to advise you of FDA’s concerns and to provide detailed information describing the findings at your facility. Your significant violations of the seafood HACCP regulation are as follows: 1. You did not implement the monitoring procedures listed in your HACCP plan for the receiving and storage of pasteurized canned crab meat to control the hazard of Clostridium botulinum (C. botulinum) growth and toxin formation to comply with 21 CFR 123.6(b). During receiving, your firm did not implement the listed monitoring procedure of using a temperature monitoring device for the finished product temperature during shipping. During storage, your firm did not implement the listed monitoring procedure of visually observing the quantity of ice. Your firm did not have monitoring records for the receiving and storage of pasteurized …
Excerpt only. The full verbatim Warning Letter is the source of truth — always read the original before regulatory decisions.
The verbatim FDA Warning Letter is the source of truth. Always read the original before acting on any analysis or summary on this page.
Read the full letter on fda.gov ↗Frequently asked questions
- What is the standard FDA response window for a warning letter?
- FDA warning letters typically require a written response within 15 working days of receipt, outlining the corrective and preventive actions the company will take.
- Has City Market, Inc. had FDA enforcement actions before?
- This is the only FDA Warning Letter Argus HQ has on file for City Market, Inc. as of 2026-06-02. Argus ingests new FDA enforcement records daily.
- What FDA violations was City Market, Inc. cited for?
- The FDA Warning Letter to City Market, Inc. (issuing office: Human Foods Program) cites: Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions. Classification: CGMP — Current Good Manufacturing Practice.
- When did FDA issue the warning letter to City Market, Inc.?
- FDA issued the letter (MARCS-CMS 727003) on 2026-05-15 and posted it publicly on fda.gov on 2026-06-02.
argus.hq
Don’t find out about the next one six weeks late.
Argus reads every FDA Warning Letter the day it publishes, summarizes it against your watchlist, and lands the ones touching your business in your inbox at 6am ET. $199/month. Cancel any time.
methodology
The analysis above is produced by Anthropic Claude Haiku 4.5 against the verbatim FDA Warning Letter excerpt and is brand-voice lint-checked before publish. The TL;DR is the same summary that ships in the customer email digest. Severity is auto-classified by Argus from the subject string and letter body using rules documented in lib/ingestion/fda-warning-letters.ts.
Argus HQ is informational only. Summaries and analyses are AI-generated and may contain errors, misclassifications, or omissions. Verify against the FDA source URL above. Argus HQ is not a law firm, accounting firm, or regulatory agency, and provides no legal, accounting, financial, medical, or regulatory advice.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Cites City Market, Inc. in 2026-05-15 Warning Letter — Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions. Digital Empire LLC. Retrieved from https://argushq.ai/fda/warning-letter/fda-wl-city-market-inc-2026-05-15-cgmp
"FDA Cites City Market, Inc. in 2026-05-15 Warning Letter — Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/fda/warning-letter/fda-wl-city-market-inc-2026-05-15-cgmp.
Argus HQ Research. "FDA Cites City Market, Inc. in 2026-05-15 Warning Letter — Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/fda/warning-letter/fda-wl-city-market-inc-2026-05-15-cgmp.
@misc{argushq_argushq_ai_fda_warning_letter_fda_wl_city_market_inc_2026_05_15_cgmp_2026,
title = {FDA Cites City Market, Inc. in 2026-05-15 Warning Letter — Seafood HACCP/CGMP for Foods/Adulterated/Insanitary Conditions},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/fda/warning-letter/fda-wl-city-market-inc-2026-05-15-cgmp},
note = {Accessed: July 13, 2026}
}